Follow
Christoph Schräder
Christoph Schräder
Immatics Biotechnologies GmbH
Verified email at immatics.com
Title
Cited by
Cited by
Year
Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in lungs and liver
SR Choudhury, L Babes, JJ Rahn, BY Ahn, KAR Goring, JC King, A Lau, ...
Cell 178 (5), 1205-1221. e17, 2019
952019
Elastin is heterogeneously cross-linked
CU Schräder, A Heinz, P Majovsky, BK Mayack, J Brinckmann, W Sippl, ...
Journal of Biological Chemistry 293 (39), 15107-15119, 2018
672018
The CHD6 chromatin remodeler is an oxidative DNA damage response factor
S Moore, ND Berger, MS Luijsterburg, CG Piett, FKT Stanley, ...
Nature communications 10 (1), 241, 2019
492019
Neprosin, a selective prolyl endoprotease for bottom-up proteomics and histone mapping
CU Schräder, L Lee, M Rey, V Sarpe, P Man, S Sharma, V Zabrouskov, ...
Molecular & Cellular Proteomics 16 (6), 1162-1171, 2017
482017
A comprehensive map of human elastin cross‐linking during elastogenesis
T Hedtke, CU Schräder, A Heinz, W Hoehenwarter, J Brinckmann, T Groth, ...
The FEBS journal 286 (18), 3594-3610, 2019
372019
Molecular-level characterization of elastin-like constructs and human aortic elastin
A Heinz, CU Schräder, S Baud, FW Keeley, SM Mithieux, AS Weiss, ...
Matrix Biology 38, 12-21, 2014
332014
Simultaneous proteoform analysis of histones H3 and H4 with a simplified middle-down proteomics method
CU Schräder, DS Ziemianowicz, K Merx, DC Schriemer
Analytical chemistry 90 (5), 3083-3090, 2018
232018
Elastins from patients with Williams–Beuren syndrome and healthy individuals differ on the molecular level
A Heinz, ACM Huertas, CU Schräder, R Pankau, A Gosch, ...
American Journal of Medical Genetics Part A 170 (7), 1832-1842, 2016
222016
In vitro cross-linking of elastin peptides and molecular characterization of the resultant biomaterials
A Heinz, CKH Ruttkies, G Jahreis, CU Schräder, K Wichapong, W Sippl, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (4), 2994-3004, 2013
222013
Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapy
GB Kim, J Fritsche, S Bunk, A Mahr, F Unverdorben, K Tosh, H Kong, ...
Science translational medicine 14 (660), eabo6135, 2022
172022
Fingerprinting desmosine-containing elastin peptides
CU Schräder, A Heinz, P Majovsky, CEH Schmelzer
Journal of The American Society for Mass Spectrometry 26 (5), 762-773, 2015
102015
IMProv: A resource for cross-link-driven structure modeling that accommodates protein dynamics
DS Ziemianowicz, D Saltzberg, T Pells, DA Crowder, C Schräder, ...
Molecular & Cellular Proteomics 20, 2021
82021
Lysine Propionylation To Boost Sequence Coverage and Enable a “Silent SILAC” Strategy for Relative Protein Quantification
CU Schräder, S Moore, AA Goodarzi, DC Schriemer
Analytical chemistry 90 (15), 9077-9084, 2018
72018
753P Targeting solid tumors with IMA402, a next-generation bispecific T cell engaging receptor against PRAME
S Missel, S Bunk, M Hofmann, G Pszolla, M Hutt, F Schwoebel, ...
Annals of Oncology 33, S888, 2022
12022
Amidated peptides and their deamidated counterparts displayed by hla-a* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, R Hannen, C Schraeder, J Fritsche, ...
US Patent App. 18/451,884, 2024
2024
Amidated peptides and their deamidated counterparts displayed by hla-a* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, R Hannen, C Schraeder, J Fritsche, ...
US Patent App. 18/472,429, 2024
2024
Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ...
US Patent App. 18/489,600, 2024
2024
Amidated peptides and their deamidated counterparts displayed by HLA-A* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, R Hannen, C Schraeder, J Fritsche, ...
US Patent 11,904,003, 2024
2024
Amidated peptides and their deamidated counterparts displayed by non-HLA-a* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ...
US Patent 11,891,427, 2024
2024
Amidated peptides and their deamidated counterparts displayed by hla-a* 02 for use in immunotherapy against different types of cancers
J Hukelmann, H Schuster, R Hannen, C Schraeder, J Fritsche, ...
US Patent App. 18/448,260, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20